Mark S. Levine - Chief Legal Officer at Immunovant, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Issuer Symbol
IMVT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark S. Levine since 28 Jan 2025

Holdings reported by Mark S. Levine for Immunovant, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 319,228 $8,124,353 $25.45 20 Nov 2024 Direct
Stock Option (right to buy) 68,723 02 Apr 2024 Direct Common Stock

Transactions reported by Mark S. Levine for Immunovant, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.